Publications by authors named "Meredith Irwin"

Claim this Profile
S
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.
Florette K Hazard, Angus M S Toland, Serena Y Tan, Bill Chiu, Naohiko Ikegaki, Meredith S Irwin

Clin Cancer Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Quality Improvement Initiative to Standardize Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors.
Kriti Kumar, Denise M Connolly, Ellen Kellington, Elyse Zelunka, Karla Kerrigan, Meredith S Irwin

Pediatr Blood Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolution of Pneumocystis jirovecii Pneumonia Prophylaxis for Pediatric Patients With Extracranial Solid Tumors: A Review of Historical Insights and Future Directions.
Kriti Kumar, Denise M Connolly, Ellen Kellington, Elyse Zelunka, Karla Kerrigan, Meredith S Irwin

Pediatr Blood Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project.
Mallory R Taylor, James R Anderson, Julie R Park, Meredith S Irwin, Mark A Applebaum

Pediatr Blood Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosomal instability degrades developmental phenotypes essential for anti-GD2 immunotherapy outcomes in high-risk neuroblastoma.
Ryan James Rebernick, Jae Eun Choi, Calvin Hesse, Noshad Hosseini, Alec Chu, Meredith Irwin

Cell Rep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR).
Jason A Jarzembowski, Fleur Webster, Klaus Beiske, Susan L Cohn, Ronald R de Krijger, Meredith S Irwin

Histopathology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
Steven G DuBois, Lucas Moreno, John Anderson, Shahab Asgharzadeh, Ro Bagatell, Meredith S Irwin

Pediatr Blood Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adults.
Joseph Flores-Toro, Subhashini Jagu, Malcolm Smith, John Shern, Douglas S Hawkins, Meredith Irwin

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International neuroblastoma risk group consortium: a model of a networking for rare cancers.
Susan L Cohn, Wendy B London, Gudrun Schleiermacher, Lucas Moreno, Inge M Ambros, Meredith S Irwin

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative single-cell transcriptomic profiling of patient-derived renal carcinoma cells in cellular and animal models of kidney cancer.
Richard Huang, Lynn Kee, Alexander Gont, Jalna Meens, Fraser G Ferens, Meredith S Irwin

FEBS Open Bio· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Incidence of Adrenal Insufficiency in Patients with High-Risk Neuroblastoma: A Single-Institution Analysis.
Daniel A Morgenstern, Sarah Cohen-Gogo, Denise Connolly, Meredith Irwin, Paul Nathan

Pediatr Blood Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study.
Esther R Berko, Arlene Naranjo, Alexander A Daniels, Samantha N McNulty, Kateryna Krytska, Meredith S Irwin

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition.
Madeline N Hayes, Sarah Cohen-Gogo, Lynn Kee, Xueting Xiong, Alex Weiss, Meredith S Irwin

Cell Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
Erin G Brown, E Stanton Adkins, Peter Mattei, Fredric A Hoffer, Sandra L Wootton-Gorges, Meredith S Irwin

J Pediatr Surg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in Children's Oncology Group neuroblastoma risk stratification through a change in age cut-off and use of INRGSS.
Wendy B London, Hannah Bousquet, Meredith S Irwin, Michael D Hogarty, Susan L Cohn

Transl Pediatr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a Faculty Awards Strategy in an Academic Department: Recognizing Faculty and Promoting the Department.
Sanjay Mahant, Simon C Ling, Suzan Williams, Prakesh Shah, Jabeen Fayyaz, Meredith S Irwin

J Pediatr· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma.
Meredith S Irwin, Kelly C Goldsmith

J Natl Compr Canc Netw· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group.
Puja J Umaretiya, Arlene Naranjo, Fan F Zhang, Meredith S Irwin, Steven G DuBois

Pediatr Blood Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline and variants.
Pauline Tibout, Joel Livingston, Nisha Kanwar, Kyoko E Yuki, Adam Shlien, Meredith S Irwin

Cold Spring Harb Mol Case Stud· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma.
Ivette Valencia-Sama, Lynn Kee, Gabriella Christopher, Michael Ohh, Mehdi Layeghifard, Meredith S Irwin

Cancer Res Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
Rochelle Bagatell, Steven G DuBois, Arlene Naranjo, Jen Belle, Kelly C Goldsmith, Meredith S Irwin

Pediatr Blood Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.
Miriam I Rosenberg, Erez Greenstein, Martin Buchkovich, Ayelet Peres, Eric Santoni-Rugiu, Meredith S Irwin

Cell Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival effect of complete surgical resection of the primary tumor in patients with metastatic, high-risk neuroblastoma in a large Canadian cohort.
Natashia M Seemann, Craig Erker, Meredith S Irwin, Steven R Lopushinsky, Ketan Kulkarni

Pediatr Blood Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
Hannah G Bender, Meredith S Irwin, Michael D Hogarty, Robert Castleberry, John M Maris

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic classification of childhood cancer using multiscale transcriptomics.
Federico Comitani, Joshua O Nash, Sarah Cohen-Gogo, Astra I Chang, Timmy T Wen, Meredith S Irwin

Nat Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis